Damien Soghoian
Biotech and healthcare venture capital
San Francisco Bay Area
Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Damien
Work Experience
2024
Venture Partner
2024
Health Security Advisor
2023
Managing Director
2022 - 2023
2018 - 2022
Director
2018 - 2022
2018 - 2022
Head of Strategy and Operations
2018 - 2022
2020 - 2021
Fellow, Ending Bioweapons Programs
2020 - 2021
2014 - 2018
Science Lead, Project Baseline Study
2017 - 2018
Project Baseline is a broad effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease.
Senior Scientist, Immunology Technical Lead, Immunoscape Platform
2014 - 2018
Verily is pursuing research in systems biology, nanotechnology, and biomedical systems engineering, with potential applications for immuno-oncology and other areas. We combine experimental capabilities with computational biology to support data generation and analysis across our clinical programs.
2014 - 2016
Scientist
2014 - 2016
Google[x], Google Life Sciences
2010 - 2014
Graduate Student
2010 - 2014
PI: Bruce Walker - Human immune profiling - CD4 and CD8 immunology - Anti-viral and vaccine immune responses - CyTOF (mass cytometry) and other high-dimensional technologies
2009 - 2014
Graduate Student
2009 - 2014
2004 - 2007
Researcher
2004 - 2007
PI: Pamela Bjorkman